N2-[(4-fluorophenyl)acetyl]-N1-[(2R,3S)-4-oxo-2-phenyl-2,3,4,5-tetrahydro-1,5-benzoxazepin-3-yl]-L-alaninamide | 680229-99-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N2-[(4-fluorophenyl)acetyl]-N1-[(2R,3S)-4-oxo-2-phenyl-2,3,4,5-tetrahydro-1,5-benzoxazepin-3-yl]-L-alaninamide
• 英文别名: (2S)-2-[[2-(4-fluorophenyl)acetyl]amino]-N-[(2R,3S)-4-oxo-2-phenyl-3,5-dihydro-2H-1,5-benzoxazepin-3-yl]propanamide
• CAS: 680229-99-6
• 化学式: C₂₆H₂₄FN₃O₄
• 分子量: 461.493
• InChiKey: IKXVMVSGDQELEG-VVMYJBMMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  34
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  96.5
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  N1-[(2R,3S)-4-Oxo-2-phenyl-2,3,4,5-tetrahydro-1,5-benzoxazepin-3-yl]-N2-(phenylacetyl)-L-alaninamide 、 4-氟苯乙酸 以to afford the title compound as a 1:1 mixture with the 2S,3R diastereomer (134 mg), white solid, m.p. 130-140° C的产率得到N2-[(4-fluorophenyl)acetyl]-N1-[(2R,3S)-4-oxo-2-phenyl-2,3,4,5-tetrahydro-1,5-benzoxazepin-3-yl]-L-alaninamide
  参考文献：
  名称：

  CHEMICAL COMPOUNDS

  摘要：

  本发明提供了一种治疗与Notch信号转导通路激活相关的疾病的新方法，包括向需要治疗的人类或动物患者施用化合物I的有效量，该化合物可以是自由形式、药学上可接受的盐形式或化合物或盐的药学上可接受的溶剂形式。

  公开号：

  US20090054398A1

文献信息

• [EN] NOVEL LACTAMS AND USES THEREOF<br/>[FR] NOUVELLES LACTAMES ET UTILISATIONS DE CES DERNIERES
  申请人：ASTRAZENECA AB

  公开号：WO2004031154A1

  公开（公告）日：2004-04-15

  Compounds having the formula (I) pharmaceutical compositions containing them and their methods of use for the treatment of neurological disorders related to amyloid ß protein production and neurological disorders such as Alzheimer's disease.. These compounds inhibit γ secretase and thereby inhibit the production of amyloid ß protein, thereby acting to prevent the formation of neurological deposits of amyloid protein.

  具有化学式（I）的化合物，含有它们的药物组合物以及它们用于治疗与淀粉样蛋白ß产生相关的神经系统疾病和阿尔茨海默病等神经系统疾病的方法。这些化合物抑制γ-分泌酶，从而抑制淀粉样蛋白ß的产生，从而防止神经系统中淀粉样蛋白的沉积形成。
• Novel lactams and uses thereof
  申请人：Becker Christopher

  公开号：US20060089346A1

  公开（公告）日：2006-04-27

  Compounds having the formula (1) pharmaceutical compositions containing them and their methods of use for the treatment of neurological disorders related to amyloid B protein production and neurological disorders such as Alzheimer's disease. These compounds inhibit γ secretase and thereby inhibit the production of amyloid β protein, thereby acting to prevent the formation of neurological deposits of amyloid protein.

  具有公式（1）的化合物，含有它们的制药组合物，以及它们的使用方法，用于治疗与淀粉样B蛋白产生相关的神经系统疾病和神经系统疾病，例如阿尔茨海默病。这些化合物抑制γ-分泌酶，从而抑制淀粉样β蛋白的产生，从而防止淀粉样蛋白的神经沉积形成。
• Novel Lactams And Uses Thereof
  申请人：Becker Christopher

  公开号：US20080076752A1

  公开（公告）日：2008-03-27

  Compounds having the formula (I) pharmaceutical compositions containing them and their methods of use for the treatment of neurological disorders related to amyloid β protein production and neurological disorders such as Alzheimer's disease. These compounds inhibit γ secretase and thereby inhibit the production of amyloid β protein, thereby acting to prevent the formation of neurological deposits of amyloid protein.

  具有公式（I）的化合物，包含它们的制药组合物以及它们的使用方法，用于治疗与淀粉样β蛋白产生有关的神经系统疾病和神经系统疾病，例如阿尔茨海默病。这些化合物抑制γ-分泌酶，从而抑制淀粉样β蛋白的产生，从而防止淀粉样蛋白的神经沉积的形成。
• Lactams and uses thereof
  申请人：Astrazeneca AB

  公开号：US07294622B2

  公开（公告）日：2007-11-13

  Compounds having the formula (I) pharmaceutical compositions containing them and their methods of use for the treatment of neurological disorders related to amyloid β protein production and neurological disorders such as Alzheimer's disease. These compounds inhibit γ secretase and thereby inhibit the production of amyloid β protein, thereby acting to prevent the formation of neurological deposits of amyloid protein.

  具有(I)式的化合物、含有它们的制药组合物以及它们的使用方法，用于治疗与淀粉样β蛋白产生相关的神经系统疾病和神经系统疾病，例如阿尔茨海默病。这些化合物抑制γ-分泌酶，从而抑制淀粉样β蛋白的产生，从而防止淀粉样蛋白的神经沉积形成。
• NOVEL LACTAMS AND USES THEREOF
  申请人：Dembofsky Bruce Thomas

  公开号：US20100160627A1

  公开（公告）日：2010-06-24

  Compounds having the formula (I) pharmaceutical compositions containing them and their methods of use for the treatment of neurological disorders related to amyloid β protein production and neurological disorders such as Alzheimer's disease. These compounds inhibit γ secretase and thereby inhibit the production of amyloid β protein, thereby acting to prevent the formation of neurological deposits of amyloid protein.

  具有公式（I）的化合物，含有它们的制药组合物以及它们用于治疗与淀粉样β蛋白产生有关的神经系统疾病和神经系统疾病，如阿尔茨海默病的方法。这些化合物抑制γ分泌酶，从而抑制淀粉样β蛋白的产生，从而防止淀粉样蛋白的神经沉积形成。